|
CN105884746A
|
|
Synthesizing method of flumatinib
|
|
CN105777714A
|
|
Method for refining flumatinib
|
|
CN105784901A
|
|
High-sensitivity analysis method for gene impurity of imatinib
|
|
CN105777651A
|
|
Crystal form of poly adenosinediphosphate-ribose polymerase (PARP) inhibitor, preparation method for crystal form and medicinal use of crystal form
|
|
CN105712928A
|
|
2-Substituted-oxy-5-methylsulfonyl pyridine piperazine acidamide analogue and preparation method and application thereof
|
|
CN106880632A
|
|
Pharmaceutical applications of c-Met specific drugs containing quinoline ring and preparation method thereof
|
|
CN106883250A
|
|
The preparation method of C-Met tyrosine kinase inhibitors
|
|
CN107001262A
|
|
The hemifumarate and its crystal formation of the proton pump inhibitor containing pyrrole ring, intermediate and medical usage
|
|
CN106137998A
|
|
Aura handkerchief Buddhist nun's pharmaceutical composition and preparation method thereof
|
|
CN106146500A
|
|
5-fluoro-3-phenyl-2-[(1S)-1-(9H-purine-6-base amino) propyl group]-4 (3H)-quinazolinone crystal formations and preparation method thereof
|
|
CN106146501A
|
|
A kind of preparation method of unformed inhibitors of kinases
|
|
CN105616419A
|
|
Pharmaceutical composition containing cyclin inhibitor solid dispersion, and preparation method thereof
|
|
CN105616418A
|
|
Pharmaceutical preparation containing cyclin inhibitor, and preparation method thereof
|
|
CN105622452A
|
|
AHU-377 crystal-type free acid, preparation method and applications thereof
|
|
CN105367438A
|
|
AHU-377alpha-phenethylamine salt polycrystalline type and preparation method and application thereof
|
|
CN105461686A
|
|
Preparation method of high purity Pradaxa crystal form
|
|
CN105330697A
|
|
Crystal form of anticancer compound, and preparation method and application thereof
|
|
CN105330706A
|
|
Canagliflozin intermediate preparation method
|
|
AU2013347383A1
|
|
Pyrrole sulfonamide derivative, preparation method for same, and medical application thereof
|
|
CN103570834A
|
|
Methoxy polyethylene glycol-modified erythropoietin mimic peptide derivative
|
